Skip to main content
BDMD
NASDAQ Industrial Applications And Services

Baird Medical Files H1 2026 Financials With Going-Concern Assessment and New Financing Disclosures

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$0.773
Mkt Cap
$25.522M
52W Low
$0.661
52W High
$3.7
52W Position info
17% above low
Off High info
79% below high
Rel. Volume info
0.3× avg
Market data snapshot near publication time

BDMD sits 17% above its 52-week low of $0.661 on light trading volume (0.3× avg).

Summary

Baird Medical's H1 2026 6-K discloses a going-concern assessment resolved only through a $2.0M support letter from its CEO and a related-party non-demand confirmation, plus new financing details.


Key Events · Earnings and Guidance · BDMD

  • Going-Concern Assessment Disclosed

    Management concluded no substantial doubt about the ability to continue as a going concern, but only after receiving a US$2.0 million financial support letter from Chairwoman/CEO Haimei Wu and a non-demand confirmation from related party Betters Medical Investment Holdings Limited.

  • Cash Position Remains Thin

    Cash and restricted cash totaled $0.29 million at June 30, 2026, while contractual obligations due within one year were $14.2 million.

  • New $525,000 Loan Disclosed

    Baird Medical LLC borrowed $525,000 in July 2026 from a Virginia limited liability company, repayable by January 26, 2027.

  • Convertible Note Proceeds Received

    The September 2026 convertible note offering received approximately US$4 million in financing proceeds on September 28, 2026.


Analysis · BDMD · Industrial Applications And Services

Baird Medical's interim financial statements reveal a going-concern assessment that management resolved only with a US$2.0 million personal financial support letter from Chairwoman/CEO Haimei Wu and a non-demand confirmation from a related party. Cash and restricted cash totaled just $0.29 million at June 30, 2026, against $14.2 million of obligations due within one year. The filing also discloses a new $525,000 loan and confirms receipt of approximately $4 million from the September convertible note offering. The going-concern discussion is a first-time disclosure and a governance red flag that warrants close attention.

How filings like this one have moved

In the 30 days to Nov 15, 2026, 48.2% of the 1980 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.20%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, BDMD was trading at $0.77 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $25.5M. The 52-week trading range was $0.66 to $3.70. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

BDMD - Latest Insights

BDMD
Nov 04, 2026, 4:45 PM EST
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $0.1034
Real-time Price: $0.0898 info
Change: -$0.0136 (-13%) info
Market Cap: $2.896M info
BDMD
Nov 02, 2026, 8:00 AM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.1502
Real-time Price: $0.0898 info
Change: -$0.0604 (-40%) info
Market Cap: $2.896M info
BDMD
Sep 30, 2026, 4:05 PM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $0.780
Real-time Price: $0.0898 info
Change: -$0.6902 (-88%) info
Market Cap: $2.896M info
BDMD
Sep 24, 2026, 4:05 PM EDT
Filing Type: 424B5
Importance Score:
9
Price at Filing: $0.760
Real-time Price: $0.0898 info
Change: -$0.6702 (-88%) info
Market Cap: $2.896M info
BDMD
Sep 03, 2026, 8:21 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $1.14
Real-time Price: $0.0898 info
Change: -$1.05 (-92%) info
Market Cap: $2.896M info